DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine
RDIF will also supply 100 million doses of Dr Reddy's after receiving Indian regulatory approval.
The company has released few details about the two cases of serious illness in its trial.
RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India
As of 1 August, Phase I and II of the vaccine were complete and by 11 August, Russian President Vladimir Putin had registered it as the world's first vaccine.
UAE announces emergency use of COVID-19 vaccine that is still in its final testing, for healthcare workers
Chinese drug giant Sinopharm began the third phase of trials for a Covid-19 vaccine in the UAE in July, with Emirati officials saying the results have been positive.
Matthew MacDougall, a neurosurgeon that works with Neuralink, they were considering implanting the chip in a paralyzed person so that they could type on a computer or form words.
Russia 'Sputnik V' vaccine promises to help people develop immunity against COVID-19 for two years: Here's all you need to know
Sputnik V can only be used on people within the age groups of 18-60 as more studies need to ensure the vaccine is safe for older people.
The vaccine is given in two doses and will help people develop immunity to the virus for at least two years.
The director of AIIMS Delhi said 'If Russia’s vaccine is successful, then we will have to see critically whether it is safe and effective.'
The Gamaleya Institute developed the Russian vaccine using a human cell line first cultured in 1973 — the same line used in the Oxford-AstraZeneca vaccine.
Philippines to conduct human trials of Russia's COVID-19 vaccine; Prez claims he has 'huge trust' in the shot
Russia says the vaccine will be supplies to the Philippines by teaming up with a local company, or the country's participation in clinical trials.
Putin announces first 'registered' COVID-19 vaccine from Russia's Gamaleya Institute; his daughter among those inoculated
The Russian Health Minister has said that plans are in motion to start a mass vaccination campaign against the novel coronavirus in October.
This final leg of human vaccine trials will recruit 5,000 volunteers above age 18 in Riyadh, Dammam and Mecca.
Human challenge trials have been used to test other vaccines but there were rescue medicines to cure those who got sick. There is no cure for COVID-19.
Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher
The vaccine has been licensed to AstraZeneca and is in its Phase III of its human trials in the UK.
The vaccine showed a “strong immune response” in animal studies and will begin human trials this month in over 1,000 subjects in multiple sites.
The antiviral drug, Remdesivir is the first drug shown to be effective against COVID-19 in human trials.
First COVID-19 vaccine to enter human trials is safe, well-tolerated and able to generate immune response against virus
The trial was carried out in 108 healthy adults with the vaccine demonstrating promising results after 28 days.
The preliminary findings, in the first eight people, must be repeated in thousands of people, to find out if the vaccine works in the real world.
Oxford University kicks off coronavirus vaccine trials: First 2 volunteers injected as scientists express 'high degree of confidence'
The Oxford vaccine project is headed by professor Sarah Gilbert and other immunity and human genetics scientists who started work on designing a coronavirus vaccine in January.